Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Cannabidiol induces autophagy via ERK1/2 activation in neural cells

Full text
Show less -
Vrechi, Talita A. M. [1] ; Leao, Anderson H. F. F. [1] ; Morais, Ingrid B. M. [1] ; Abilio, Vanessa C. [1] ; Zuardi, Antonio W. [2, 3] ; Hallak, Jaime Eduardo C. [2, 3] ; Crippa, Jose Alexandre [2, 3] ; Bincoletto, Claudia [1] ; Ureshino, Rodrigo P. [4, 5] ; Smaili, Soraya S. [1] ; Pereira, Gustavo J. S. [1]
Total Authors: 11
[1] Univ Fed Sao Paulo, Dept Pharmacol, Escola Paulista Med, Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav, Ribeirao Preto - Brazil
[3] Natl Council Sci & Technol Dev CNPq CAPES FAPESP, Natl Inst Translat Med INCT TM, Ribeirao Preto - Brazil
[4] Univ Fed Sao Paulo, Lab Mol & Translat Endocrinol, Escola Paulista Med, Sao Paulo, SP - Brazil
[5] Univ Fed Sao Paulo, Dept Biol Sci, Diadema Campus, Diadema, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: SCIENTIFIC REPORTS; v. 11, n. 1 MAR 8 2021.
Web of Science Citations: 3

Autophagy is a lysosomal catabolic process essential to cell homeostasis and is related to the neuroprotection of the central nervous system. Cannabidiol (CBD) is a non-psychotropic phytocannabinoid present in Cannabis sativa. Many therapeutic actions have been linked to this compound, including autophagy activation. However, the precise underlying molecular mechanisms remain unclear, and the downstream functional significance of these actions has yet to be determined. Here, we investigated CBD-evoked effects on autophagy in human neuroblastoma SH-SY5Y and murine astrocyte cell lines. We found that CBD-induced autophagy was substantially reduced in the presence of CB1, CB2 and TRPV1 receptor antagonists, AM 251, AM 630 and capsazepine, respectively. This result strongly indicates that the activation of these receptors mediates the autophagic flux. Additionally, we demonstrated that CBD activates autophagy through ERK1/2 activation and AKT suppression. Interestingly, CBD-mediated autophagy activation is dependent on the autophagy initiator ULK1, but mTORC1 independent. Thus, it is plausible that a non-canonical pathway is involved. Our findings collectively provide evidence that CBD stimulates autophagy signal transduction via crosstalk between the ERK1/2 and AKT kinases, which represent putative regulators of cell proliferation and survival. Furthermore, our study sheds light on potential therapeutic cannabinoid targets that could be developed for treating neurodegenerative disorders. (AU)

FAPESP's process: 18/06260-8 - Study of cannabinoid compounds modulation in the autophagy mediated by TFEB in a cellular tauophathy model
Grantee:Talita Aparecida de Moraes Vrechi
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 19/02821-8 - Autophagy modulation by cannabinoids: neuroprotection in Parkinson's Disease
Grantee:Soraya Soubhi Smaili
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 19/14722-4 - Two-Pore Channels receptors and TFEB-3 autophagy modulation in human hepatocellular carcinoma
Grantee:Gustavo José da Silva Pereira
Support Opportunities: Regular Research Grants
FAPESP's process: 17/10863-7 - Study of lipophagy mediated by two-pore channels receptors
Grantee:Gustavo José da Silva Pereira
Support Opportunities: Regular Research Grants
FAPESP's process: 16/20796-2 - Study of estrogen receptors mediated autophagy against tau toxicity in cell and zebrafish models
Grantee:Rodrigo Portes Ureshino
Support Opportunities: Research Grants - Young Investigators Grants